Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplificationJieyi Wang(AbbVie (United States)), Edward B. Reilly(AbbVie (United States))BMC CancerFebruary 16, 201610.1186/s12885-016-2138-zCited by 62SaveCiteExport RISWatch citationsRelated PapersGenetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells|BMC Cancer|2014|28Insulin-like Growth Factor-1 Receptor and ErbB Kinase Inhibitor Combinations Block Proliferation and Induce Apoptosis through Cyclin D1 Reduction and Bax Activation|Journal of Biological Chemistry|2008|24